| 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus A Fanouriakis, M Kostopoulou, A Alunno, M Aringer, I Bajema, JN Boletis, ... Annals of the rheumatic diseases 78 (6), 736-745, 2019 | 2077 | 2019 |
| Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects M Colina, M Govoni, C Orzincolo, F Trotta Arthritis Care & Research: Official Journal of the American College of …, 2009 | 311 | 2009 |
| Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived … C Vitali, G Palombi, C Baldini, M Benucci, S Bombardieri, M Covelli, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 245 | 2007 |
| Efficacy and safety of epratuzumab in moderately to severely active systemic lupus erythematosus: results from two phase III randomized, double‐blind, placebo‐controlled trials MEB Clowse, DJ Wallace, RA Furie, MA Petri, MC Pike, P Leszczyński, ... Arthritis & rheumatology 69 (2), 362-375, 2017 | 240 | 2017 |
| The diagnosis and clinical management of the neuropsychiatric manifestations of lupus M Govoni, A Bortoluzzi, M Padovan, E Silvagni, M Borrelli, F Donelli, ... Journal of autoimmunity 74, 41-72, 2016 | 208 | 2016 |
| Clinical spectrum time course in anti Jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study L Cavagna, L Nuno, CA Scire, M Govoni, FJL Longo, F Franceschini, ... Medicine 94 (32), e1144, 2015 | 204 | 2015 |
| Central nervous system involvement in Sjögren’s syndrome: unusual, but not unremarkable—clinical, serological characteristics and outcomes in a large cohort of Italian patients A Massara, S Bonazza, G Castellino, L Caniatti, F Trotta, M Borrelli, ... Rheumatology 49 (8), 1540-1549, 2010 | 202 | 2010 |
| Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the … F Atzeni, P Sarzi-Puttini, C Botsios, A Carletto, P Cipriani, EG Favalli, ... Autoimmunity reviews 12 (2), 225-229, 2012 | 200 | 2012 |
| Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course L Cavagna, E Trallero-Araguás, F Meloni, I Cavazzana, J Rojas-Serrano, ... Journal of clinical medicine 8 (11), 2013, 2019 | 189 | 2019 |
| HLA‐G genotype and HLA‐G expression in systemic lupus erythematosus: HLA‐G as a putative susceptibility gene in systemic lupus erythematosus R Rizzo, TVF Hviid, M Govoni, M Padovan, M Rubini, L Melchiorri, ... Tissue antigens 71 (6), 520-529, 2008 | 185 | 2008 |
| Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus A Bortoluzzi, CA Scire, S Bombardieri, L Caniatti, F Conti, S De Vita, ... Rheumatology 54 (5), 891-898, 2015 | 182 | 2015 |
| Adult-onset Still’s disease V Bagnari, M Colina, G Ciancio, M Govoni, F Trotta Rheumatology International 30, 855-862, 2010 | 171 | 2010 |
| Body weight, gender and response to TNF-α blockers in axial spondyloarthritis E Gremese, S Bernardi, S Bonazza, M Nowik, G Peluso, A Massara, ... Rheumatology 53 (5), 875-881, 2014 | 163 | 2014 |
| A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory … K Varani, M Padovan, F Vincenzi, M Targa, F Trotta, M Govoni, PA Borea Arthritis research & therapy 13, 1-13, 2011 | 163 | 2011 |
| A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study M Elhai, J Avouac, UA Walker, M Matucci-Cerinic, G Riemekasten, P Airò, ... Annals of the rheumatic diseases 75 (1), 163-169, 2016 | 152 | 2016 |
| Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry L Iaccarino, E Bartoloni, L Carli, F Ceccarelli, F Conti, S De Vita, ... Clinical and experimental rheumatology 33 (4), 449-456, 2015 | 149 | 2015 |
| SAPHO syndrome and infections M Govoni, M Colina, A Massara, F Trotta Autoimmunity reviews 8 (3), 256-259, 2009 | 129 | 2009 |
| Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric … L Iaccarino, L Andreoli, EB Bocci, A Bortoluzzi, F Ceccarelli, F Conti, ... Journal of autoimmunity 86, 1-8, 2018 | 126 | 2018 |
| Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature C Ferri, M Sebastiani, AL Monaco, M Iudici, D Giuggioli, F Furini, ... Autoimmunity reviews 13 (10), 1026-1034, 2014 | 126 | 2014 |
| Elderly onset rheumatoid arthritis: clinical aspects G Bajocchi, R La Corte, A Locaputo, M Govoni, F Trotta Clinical and experimental rheumatology 18 (4; SUPP/20), S-49, 2000 | 122 | 2000 |
Alessandra BortoluzziUniversity of FerraraE-mailová adresa ověřena na: unife.it
